| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| Flow cytometric analysis showed that TMVA did not bind to platelet GPIX , GPIIb , GPIIIa , GPIa , GPIIa and GPIV . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| This activity is not mediated by the platelet collagen receptor integrin alpha 2 beta 1 . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| Signal transducing mechanisms involved in activation of the platelet collagen receptor integrin alpha ( 2 ) beta ( 1 ) . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| Integrin alpha 4 beta 1 and glycoprotein 4 ( CD 36 ) are expressed on circulating reticulocytes in sickle cell anemia . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| The blasts expressed CD 36 and CD 71 but not lymphoid antigens , myeloid antigens , CD 41 or glycophorin A . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| Assignment of human platelet GP2B ( GPIIb ) gene to chromosome 17 , region q21 . 1 q21 . 3 . ^^^ The gene coding for GPIIb was located on 17q21 . 1 17q21 . 3 as determined by in situ hybridization with a 2650 bp GP2B ( GPIIb ) cDNA probe prepared from human megakaryocytes . . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| In this study , we constructed a VSV G pseudotyped , human immunodeficiency virus type 1 based , self inactivating lentivirus vector that expressed green fluorescent protein ( GFP ) under the control of the human CD 41 ( glycoprotein 2b ; GP2b ) promoter ; this activity is restricted to megakaryocytic lineage cells . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| The specific increase in platelet GPIV in patients with essential thrombocythemia was confirmed by immunoblot analysis whereas no increase in platelet GPIb or GPIIb IIIa was observed by this technique . . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| Gold particles identifying glycoprotein ( GP ) Ib ( CD42b ) and GPIIb IIIa ( CD41a ) remained distributed over the entire platelet surface , whereas gold particles identifying GPIa IIa ( CDw 49b ) and GPIV ( CD 36 ) were found essentially overlying the granulomere ; p 24 ( CD 9 ) was present at the peripheral platelet rim and over the cell body . ^^^ An increased labeling of GPIIb IIIa , GPIV and p 24 was also observed on pseudopods , with GPIIb IIIa and GPIV concentrated at the enlarged extremities and at sites of contact between two platelets , whereas GPIb was absent from pseudopods . ^^^ Double labeling experiments showed colocalization of Fg and TSP , GPIV and TSP , as well as Fg and GPIIb IIIa , although no typical coclustering of GPIIb IIIa and GPIV or GPIIb IIIa and p 24 was apparent . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| We found that platelets from 20 normal donors varied significantly in their sensitivity to three IgG 1 murine MoAbs specific for membrane glycoproteins CD 9 , GPIV ( CD 36 ) , and the GPIIb / IIIa complex ( CD 41 ) , respectively . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| Adherence was unaffected by monospecific polyclonal antibodies to glycoprotein ( GP ) Ib and GPIV , and was normal with platelets from two patients with Glanzmann ' s thrombasthaenia , indicating that GPIb , the GPIIb / IIIa complex and GPIV are not involved in platelet laminin interaction . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| In addition , autoradiography of the gels showed a 125I 105 Kd GP , identified by immunoblot as GPIIIa , as well as GPIb , GPIIb , and another band at 87 Kd , probably GPIV . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| In contrast , in the presence of 2 mM Ca2+ and 1 mM Mg2+ , 5G11 precipitated a complex of five radiolabeled proteins , among which GPIIb , GPIIIa and GPIV were the most prominent . . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| A panel of fluorescent labeled monoclonal antibodies was used to monitor activation dependent platelet surface changes : downregulation of glycoprotein ( GP ) Ib ( 6D1 ) and upregulation of GMP 140 ( S 12 ) , the GPIIb IIIa complex ( PAC 1 ) , and GPIV ( OKM 5 ) . ^^^ These changes were more readily detected with monoclonal antibodies directed against GPIb ( 6D1 ) and , to a lesser extent , GPIV ( OKM 5 ) rather than those directed against the GPIIb IIIa complex ( PAC 1 ) and GMP 140 ( S 12 ) . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| All these 15 patients had antibodies against GPIIb / IIIa , five patients against GPIb / IX , and six patients against GPIV . ^^^ Anti GPIb / IX and GPIV occurred only in combination with anti GPIIb / IIIa antibodies . ^^^ Eluates from platelets contained only GPIIb / IIIa reactivities , but neither anti GPIb / IX nor anti GPIV . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| Change in platelet surface markers were measured by flow cytometry , using fluorescein conjugated antibodies to fibrinogen , P selectin ( CD62P ) , GPIIb IIIa ( CD 41 ) , GPIb alpha ( CD42b ) and GPV ( CD42d ) , and fluorescein conjugated Annexin 5 was used to measure expression of anionic phospholipid . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| Modifications in the presence of platelet glycoproteins GPIb ( CD42b ) , GPIIIa ( CD 41 ) and GPIV ( CD 36 ) , expression of specific platelet markers ( P selectin ( CD62P ) and lysosomal protein ( CD 63 ) ) and leukocyte integrin ( CD11b ) were assessed during hemodialysis . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| Platelets from patients with TTP did , however , have significantly reduced levels of GPIIb / IIIa prior to plasmapheresis ( mean 36 348 5 52 505 molecules / platelet in controls ; P = 0 . 0004 ) and of GPIV ( mean 13 321 5 26 212 molecules / platelet in controls ; P = 0 . 0002 ) . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| We observed a reduced cell surface expression of GPIb ( p < 0 . 01 ) and GPIIb / IIIa ( p < 0 . 01 ) , while GPIa / IIa and GPIV expression was only marginally different between patients and controls . ^^^ In contrast , there was a two fold increase of platelet GPIb and GPIIb RNA and a three fold increase of GPIV RNA among MDS patients . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| Cell sorting studies revealed that the CD 41 ( + ) GPV ( + ) population contained 4N and 8N cells at day 7 , and was less effective than CD 41 ( + ) GPV ( ) cells in generating burst forming units of erythrocytes or MK colonies . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| Activation of the platelet collagen receptor integrin alpha ( 2 ) beta ( 1 ) : its mechanism and participation in the physiological functions of platelets . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| The contribution of the first platelet collagen receptor identified , integrin alpha ( 2 ) beta ( 1 ) , remains controversial . alpha ( 2 ) beta ( 1 ) is not required for platelet responses to collagen under many experimental conditions but GPVI and other intracellular signals may activate the integrin , which is likely to play a later , secondary role . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| Both bone marrow megakaryocytes and platelets from healthy volunteers stained > 75 % positive for CD 36 , CD 41 , CD 42 , Cdw49b ( alpha subunit VLA 2 ) , Cdw49e ( alpha subunit VLA 5 ) , Cdw49f ( alpha subunit VLA 6 ) and CD 62 . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| MKPL 1 cells were positive for platelet GPIIb / IIIa ( CD 41 ) and GPIIIa ( CD 61 ) , and expressed OKM 5 ( CD 36 ) , MY 7 ( CD 13 ) , and MY 9 ( CD 33 ) antigens in the absence of erythroid and lymphoid markers . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| The cell line expresses CD 34 , CD 7 , TdT , and myeloid ( CD 13 , CD 14 , CD 33 ) and megakaryocyte / platelet ( CD 36 , CD 41 , CD42b , CDw49b ) antigens . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| A majority of the cells from peripheral blood coexpressed the antigens against MAbs CD 2 , CD 3 , CD 4 , CD 5 , Ti ( WT 31 ) , CD 25 , CD 38 , CD 45 , and CD 29 , but did not express the antigens against CD 1 , CD 13 , CD 14 , CD 33 , CD 36 , CD 10 , CD 19 , CD 20 , CD 21 , CD 24 , CD 41 , CD 42 , CD45RA , CD 56 , and CD 57 . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| The blasts were positive for CD 7 , CD 11 , CD 13 , CD 33 , CD 36 , CD 41 and CD 42 , suggesting that the blasts had the surface phenotypes of both myeloid and megakaryocytoid lineage . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| The blasts of one case possessed both platelet GpIb and GpIIb / IIIa cell surface antigens detected by 5F1 ( CD 36 ) , AN 51 ( CDw 42 ) , and J 15 , P 2 and HPL 2 ( CDw 41 ) , respectively , whereas the remaining two cases almost completely lacked Gp1b cell surface antigen . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| Only a small proportion of CD34+ cells coexpressed CD 4 ( 15 . 5 + / 11 . 7 % , CD 36 ( 31 . 7 + / 6 . 2 % ) , CD 61 ( 16 . 3 + / 12 . 9 % ) , CD 41 ( 6 . 5 + / 5 . 5 % ) or the lymphoid associated markers CD 10 ( 18 . 6 + / 11 . 8 % ) and CD 19 ( 12 . 3 + / 13 . 2 % ) . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| Although activation of platelets with purified complement components results in a slow morphologic change without aggregation , involvement of CD 36 results in rapid complement mediated activation leading to formation of small aggregates that is largely independent of GPIIb / IIIa and that , under certain circumstances , proceeds to the formation of large ADP dependent aggregates . . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| Platelet membrane glycoprotein ( GP ) 4 ( also called CD 36 and GPIIb ) deficiency is associated with N ( aka ) negative platelets . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| Using the cDNA PCR it was seen that the mRNA phenotype of a small number of sorted CD34+ cells ( purity > 98 % ) was negative for the markers CD 2 , CD 14 , CD 16 , CD 20 , CD 21 , CD 22 , CD41b , and glycophorin A that are expressed on differentiated cells but positive for CD 34 , CD 7 , CD 19 , CD 36 , and CD 61 . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| A majority of cells had a blast morphology with the phenotype of a myeloid hematopoietic progenitor , ie , CD34+ , CD33+ , CD13+ , HLA DR+ , but CD 38 , and the remaining cells ( 5 % to 10 % ) expressed platelet restricted proteins such as CD 41 , CD 42 , CD 36 , CD 61 , and von Willebrand factor ; some of them were polyploid ( up to 32N ) and exhibited demarcation membranes and alpha granules . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| A fifty five year old male presenting as FAB M 6 had blasts that were positive both for erythroblastic and megakaryocytic surface makers , i . e . , carbonic anhydrase 1 , CD 36 and CD 41 . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| CD 16 , CD 20 , CD 24 , CD 25 , CD 28 , CD 31 , CD 32 , CD 36 , CD 39 , CD 41 , CD 42 , CD 47 , CD 49 , CD 50 and CD 54 ) which ranged from minor to significant in scope and magnitude . . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| Circulating blasts were positive for CD 4 , CD 7 , CD 25 , CD 13 , CD 33 , CD 34 , and HLA DR and partly positive for CD 41 and CD 36 . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| Molecules implicated as collagen receptors include the integrin alpha 2 beta 1 , CD 36 and GPVI and involve a novel signalling pathway . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| This is the case for the glycoprotein ( GP ) IIb IIIa ( CD 41 ) , CD 36 , CD 9 , PECAM 1 , and Rap1b , while the GPIB 9 5 complex was considered to escape the rule . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| The Kasumi 4 cells had the following characteristic features : undifferentiated blasts which were positive from CD 34 , CD 33 and CD 13 surface markers , but negative for myeloperoxidase platelet peroxidase , CD 36 , CD 41 and CD 42 ; chromosome abnormalities of t ( 9 ; 22 ; 11 ) ( q 34 ; q 11 ; q 13 ) , inv ( 3 ) ( q21q26 ) ; and elevated expression of EVI 1 gene which is located at chromosome band 3q26 . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| Thrombin activation resulted in significant increases in platelet surface expression of CD62P , CD 63 , CD 41 , CD 9 , and CD 36 in neonates and their healthy mothers . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| These cells have many characteristics of late erythroid progenitor cells , they are positive for CD 36 , Glycophorin A , and CD 71 but negative for CD 41 , and positive for benzidine and PAS staining . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| BEAS 2B cells were also found to constitutively express CD 9 , CD 13 , CD 15 , CD15s , CD 23 , CD 33 , CD 36 , CD 40 , CD41b , CD42b , CD 48 , CD 50 , CD 71 , and CD 102 ( ICAM 2 ) . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| Exposure of normal resting platelets to P FVIII resulted in platelet activation , as manifested by increased expression of the platelet surface activation markers CD 62 , CD 63 , and activated GPIIbIIIa , and by activation induced modulation of expression of normal platelet membrane glycoproteins CD 41 , CD 42 , and CD 36 . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| At their cell surface the erythroid / megakaryocytic markers CD 36 and CD 41 , and the erythroid specific glycophorin A can be detected , while haemoglobin can be detected antigenically in the cytoplasm . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| A three color flow cytometric analysis was performed and revealed two different CD 45 dim , CD 34 ( + ) , CD 117 ( + ) , CD 56 ( + ) immature subpopulations : the normal immature myeloid precursor and an immature blast cell population that expressed CD 41 , CD 42 , CD 61 , CD 36 , CD 13 , CD1a , and CD 2 . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| Most ( > 75 % ) agreed that at least one more B ( CD 20 , CD 22 , CD79a , IgM ) , T ( CD1a , CD 2 , CD 4 , CD 5 , CD 8 ) , myeloid ( CD11b , CD 15 , CD 64 , CD 117 , myeloperoxidase ) , erythroid ( CD 36 , CD 71 , glycophorin A ) , and megakaryocytic ( CD 41 , CD 61 ) reagents should be included in the essential panel . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| MLSC was able to measure antigens CD 9 , CD 29 , CD 36 , CD 41 , CD42a , CD42b , and CD 61 on platelets and determine an average of 2 . 3 10 10 ( 5 ) + / 7 10 10 ( 4 ) platelets per microliter . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| The multi functional platelet receptor CD 36 selectively partitioned into DRMs , whereas the GPI linked protein CD 55 and the major platelet integrin alpha ( IIb ) beta ( 3a ) did not , which suggests that the clustering of proteins within rafts is a regulated process dependent on specific lipid protein interactions . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| Flotation experiments after CHAPS lysis of platelets revealed a distinct set of lipid raft associated proteins , which were identified by matrix assisted laser desorption / ionization mass spectrometry as stomatin , flotillin 1 , flotillin 2 , CD 36 , CD 9 , integrin alpha ( IIb ) beta ( 3 ) , and the glucose transporter GLUT 3 . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| Preincubation of platelets with ox PAPC alone , significantly up regulated CD62p and CD 41 receptors ( higher dose ) but potently inhibited anti CD 36 MoAb binding . ^^^ Okadaic acid increased anti CD 41 and decreased anti CD 36 and anti CD42b MoAbs binding . ^^^ The effect of okadaic acid on CD 36 and CD 41 argue for the participation of phosphorylation dependent reorganization of cellular trafficking and microtubule organization by ox PAPC . . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| MOLM 16 revealed characteristics of the megakaryocytic lineage in terms of immunophenotyping being positive for CD 9 , CD 31 , CD 36 , CD 41 , CD 61 , CD62P , CD 63 , CD 110 , CD 151 , thrombospondin , von Willebrand factor ( vWf ) , and fibrinogen . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| In the same group the expression of all constitutive membrane markers was statistically significantly decreased : in patients undergoing PTCA was the expression of CD 9 : 87 . 98 % ( in comparison with control group 94 . 98 % ) , CD 31 : 87 . 10 % ( 92 . 78 % ) , CD 36 : 87 . 37 % ( 90 . 98 % ) , CD 41 : 88 . 09 % ( 95 . 62 % ) , CD42a : 88 . 54 % ( 94 . 98 % ) , CD42a : 88 . 31 % ( 94 . 13 % ) . . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| This study was undertaken to examine the tissue distribution of a broad spectrum of monoclonal antibodies ( mAbs ) containing tetraspan antigens ( CD 9 , CD 63 , CD 151 ) , endothelial cell antigens ( CD 31 , CD 36 , CD 105 , CD 106 , CD 146 ) , integrins ( CD49a f , CD 29 , CD 41 , CD 51 , CD 61 ) , CD 39 , CD 98 , CD 99 , CD 143 and , CD 147 supplied from fifth and sixth international workshops and conferences on human leukocyte differentiation antigens in a comparative manner in human OA and normal synovium . ^^^ |
|
| Interacting proteins: P16671 and P08514 |
Pubmed |
SVM Score :0.0 |
| Formation of disulfide linked complexes between the three minor envelope glycoproteins ( GP2b , GP 3 , and GP 4 ) of equine arteritis virus . ^^^ |
|